Brazil: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Brazil

In 2022, the Brazilian market for other medicaments for therapeutic or prophylactic uses increased by X% to $X, rising for the second year in a row after two years of decline. Overall, the total consumption indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2020 indices. As a result, consumption attained the peak level of $X. From 2019 to 2022, the growth of the market failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Brazil

Exports of other medicaments for therapeutic or prophylactic uses from Brazil skyrocketed to X tons in 2022, jumping by X% on the previous year's figure. In general, exports recorded a significant increase. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. Over the period under review, the exports of hit record highs in 2022 and are likely to see steady growth in the near future.

In value terms, exports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Over the period under review, exports recorded a moderate increase. The pace of growth was the most pronounced in 2013 when exports increased by X% against the previous year. As a result, the exports attained the peak of $X. From 2014 to 2022, the growth of the exports of failed to regain momentum.

Exports by Country

Paraguay (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Brazil, with a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Paraguay exceeded the volume sent to the second major destination, Venezuela (X tons), threefold. Chile (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Paraguay amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Venezuela (X% per year) and Chile (X% per year).

In value terms, the largest markets for other medicaments for therapeutic or prophylactic uses exported from Brazil were Venezuela ($X), Chile ($X) and the United States ($X), with a combined X% share of total exports.

Among the main countries of destination, the United States, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, falling by X% against the previous year. Over the period under review, the export price continues to indicate a abrupt decrease. The pace of growth appeared the most rapid in 2018 when the average export price increased by X% against the previous year. The export price peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Paraguay ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%), while the prices for the other major destinations experienced a decline.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Brazil

For the third year in a row, Brazil recorded growth in supplies from abroad of other medicaments for therapeutic or prophylactic uses, which increased by X% to X tons in 2022. The total import volume increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of X%. Imports peaked in 2022 and are expected to retain growth in the immediate term.

In value terms, imports of other medicaments for therapeutic or prophylactic uses reached $X in 2022. Overall, total imports indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2020 indices. The growth pace was the most rapid in 2018 when imports increased by X%. As a result, imports attained the peak of $X. From 2019 to 2022, the growth of imports of remained at a lower figure.

Imports by Country

India (X tons), China (X tons) and the United States (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Brazil, with a combined X% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by China (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, India ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Brazil, comprising X% of total imports. The second position in the ranking was taken by China ($X), with a X% share of total imports. It was followed by Germany, with a X% share.

From 2012 to 2022, the average annual growth rate of value from India stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: China (X% per year) and Germany (X% per year).

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, growing by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The growth pace was the most rapid in 2018 when the average import price increased by X%. As a result, import price attained the peak level of $X per ton. From 2019 to 2022, the average import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was India ($X per ton), while the price for the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :